Primer: Alexion Pharmaceuticals (ALXN US) - Sep 2026
Alexion Pharmaceuticals (ALXN) maintains an entrenched global leadership in complement-mediated rare diseases, anchored by its blockbuster...
87 Views
𝛼SK or SearchENTITY
Alexion Pharmaceuticals (ALXN US)
Alexion Pharmaceuticals (ALXN US)
39
Analysis
Health Care • United States
Alexion Pharmaceuticals, Inc., a biopharmaceutical company, researches and develops proprietary immunoregulatory compounds for the treatment of autoimmune and cardiovascular diseases. The Company develops C5 complement inhibitors and Apogens which are two classes of potential therapeutic compounds designed to selectively target specific disease-causing segments of the immune system.
morex